Rodriguez E
Eur J Immunol. 2025; 55(3):e202451318.
PMID: 40071681
PMC: 11898543.
DOI: 10.1002/eji.202451318.
Nakisa A, Sempere L, Chen X, Qu L, Woldring D, Crawford H
ChemMedChem. 2024; 19(24):e202400491.
PMID: 39230966
PMC: 11648843.
DOI: 10.1002/cmdc.202400491.
Marciel M, Haldar B, Hwang J, Bhalerao N, Bellis S
Adv Cancer Res. 2023; 157:123-155.
PMID: 36725107
PMC: 11342334.
DOI: 10.1016/bs.acr.2022.07.003.
Xu Y, Wang Y, Hoti N, Clark D, Chen S, Zhang H
Mass Spectrom Rev. 2021; 42(2):822-843.
PMID: 34766650
PMC: 9095761.
DOI: 10.1002/mas.21748.
Thurin M
Monoclon Antib Immunodiagn Immunother. 2021; 40(3):89-100.
PMID: 34161162
PMC: 8336226.
DOI: 10.1089/mab.2021.0024.
Application of the Antibody-Inducing Activity of Glycosphingolipids to Human Diseases.
Okuda T
Int J Mol Sci. 2021; 22(7).
PMID: 33917390
PMC: 8038663.
DOI: 10.3390/ijms22073776.
Induction of specific adaptive immune responses by immunization with newly designed artificial glycosphingolipids.
Okuda T, Shimizu K, Hasaba S, Date M
Sci Rep. 2019; 9(1):18803.
PMID: 31827147
PMC: 6906409.
DOI: 10.1038/s41598-019-55088-9.
The glycosylation landscape of pancreatic cancer.
Munkley J
Oncol Lett. 2019; 17(3):2569-2575.
PMID: 30854032
PMC: 6388511.
DOI: 10.3892/ol.2019.9885.
The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.
Staal B, Liu Y, Barnett D, Hsueh P, He Z, Gao C
Clin Cancer Res. 2019; 25(9):2745-2754.
PMID: 30617132
PMC: 7246054.
DOI: 10.1158/1078-0432.CCR-18-3310.
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
Osuga T, Takimoto R, Ono M, Hirakawa M, Yoshida M, Okagawa Y
J Natl Cancer Inst. 2016; 108(8).
PMID: 27075853
PMC: 5017955.
DOI: 10.1093/jnci/djw038.
Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.
Tang H, Partyka K, Hsueh P, Sinha J, Kletter D, Zeh H
Cell Mol Gastroenterol Hepatol. 2016; 2(2):201-221.e15.
PMID: 26998508
PMC: 4792034.
DOI: 10.1016/j.jcmgh.2015.12.003.
Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
Tang H, Singh S, Partyka K, Kletter D, Hsueh P, Yadav J
Mol Cell Proteomics. 2015; 14(5):1323-33.
PMID: 25733690
PMC: 4424402.
DOI: 10.1074/mcp.M114.047837.
The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.
Tang H, Hsueh P, Kletter D, Bern M, Haab B
Adv Cancer Res. 2015; 126:167-202.
PMID: 25727148
PMC: 4484597.
DOI: 10.1016/bs.acr.2014.11.003.
Remembrances of Hilary Koprowski from a Surgeon's Perspective.
Sears H
Monoclon Antib Immunodiagn Immunother. 2014; 33(3):173-6.
PMID: 24937249
PMC: 4066234.
DOI: 10.1089/mab.2014.0052.
CA 19-9 and pancreatic cancer.
Wu E, Zhou S, Bhat K, Ma Q
Clin Adv Hematol Oncol. 2013; 11(1):53-5.
PMID: 23596673
PMC: 3633106.
Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.
Diamandis E, Bast Jr R, Gold P, Chu T, Magnani J
Clin Chem. 2012; 59(1):22-31.
PMID: 23204222
PMC: 3983776.
DOI: 10.1373/clinchem.2012.187047.
AB0 blood group and prognosis in patients with pancreatic cancer.
Rahbari N, Bork U, Hinz U, Leo A, Kirchberg J, Koch M
BMC Cancer. 2012; 12:319.
PMID: 22838843
PMC: 3488322.
DOI: 10.1186/1471-2407-12-319.
Shotgun glycomics: a microarray strategy for functional glycomics.
Song X, Lasanajak Y, Xia B, Heimburg-Molinaro J, Rhea J, Ju H
Nat Methods. 2010; 8(1):85-90.
PMID: 21131969
PMC: 3074519.
DOI: 10.1038/nmeth.1540.
Complexomics study of two Helicobacter pylori strains of two pathological origins: potential targets for vaccine development and new insight in bacteria metabolism.
Bernarde C, Lehours P, Lasserre J, Castroviejo M, Bonneu M, Megraud F
Mol Cell Proteomics. 2010; 9(12):2796-826.
PMID: 20610778
PMC: 3101863.
DOI: 10.1074/mcp.M110.001065.
From carbohydrate leads to glycomimetic drugs.
Ernst B, Magnani J
Nat Rev Drug Discov. 2009; 8(8):661-77.
PMID: 19629075
PMC: 7097102.
DOI: 10.1038/nrd2852.